We will review the use of traditional complement proteins, C3 and C4, and compare them to complement activation (split) products in plasma and on cell surfaces in relation to their application to SLE diagnosis and monitoring of disease activity. The gene discussed is VTN; the disease is systemic lupus erythematosus.